› 4g5j

X-ray diffraction
2.8Å resolution

Crystal structure of EGFR kinase in complex with BIBW2992

Released:
DOI: 10.2210/pdb4g5j/pdb
PDB entry 4g5j coloured by chain, front view.
PDB entry 4g5j coloured by chain, side view.
PDB entry 4g5j coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker.
Solca F, Dahl G, Zoephel A, Bader G, Sanderson M, Klein C, Kraemer O, Himmelsbach F, Haaksma E, Adolf GR
J Pharmacol Exp Ther 343 342-50 (2012)
PMID: 22888144

Function and Biology Details

Reaction catalysed: 
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate
Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assemblies composition:
monomeric (preferred)
homo dimer
Assembly name:
PDBe Complex ID:
PDB-CPX-132671 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Epidermal growth factor receptor Chain: A
Molecule details ›
Chain: A
Length: 330 amino acids
Theoretical weight: 37.58 KDa
Source organism: Homo sapiens
Expression system: Not provided
UniProt:
  • Canonical: P00533 (Residues: 696-1022; Coverage: 28%)
Gene names: EGFR, ERBB, ERBB1, HER1
Sequence domains: Protein tyrosine and serine/threonine kinase
Structure domains:

Ligands and Environments

2 bound ligands:
Ligand 0WN 1 x 0WN
Ligand 0WM 2 x 0WM
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: SLS BEAMLINE X06SA
Spacegroup: I23
Unit cell:
a: 144.468Å b: 144.468Å c: 144.468Å
α: 90° β: 90° γ: 90°
R-values:
R R work R free
0.208 0.205 0.259
Expression system: Not provided

Quick links

Citations

147 review citations

The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R. (2014)
146 more

48 mentions without citation

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.
Gonzalez de Castro et al. (2013)
47 more